TENS 7000 Rechargeable 4 Channel (TENS 7000H)
Shenzhen Dongdixin Technology Co., Ltd. · Decision date Jun 26, 2026
What did the FDA decide?
FDA records K260412 as a 510(k) premarket notification, with a decision dated Jun 26, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Jun 26, 2026
Regulatory record facts
- Identifier
- K260412
- Regulatory pathway
- 510(k) premarket notification
- Product code
- NUH
- Decision code
- SESE
- Decision date
- Jun 26, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, Nerve, Transcutaneous, Over-The-Counter.
- Product code
- NUH
- FDA device class
- 2
FDA decision timeline
K260412 received
Application receipt date recorded by FDA.
K260412 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NUH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Hong Qiangxing (Shenzhen) Electronics Limited | 510(k) clearance | Oct 16, 2026 | FDA | |
| Shenzhen Osto Medical Technology Co.,Ltd | 510(k) clearance | Sep 6, 2026 | FDA | |
| Hivox Biotek, Inc. | 510(k) clearance | Jun 16, 2026 | FDA | |
TENS/EMS device (GUSE01)K253896 | Globalcare Medical Technology Co., Ltd. | 510(k) clearance | Mar 4, 2026 | FDA |
| Shenzhen Jiantuo Electronics Co., Ltd. | 510(k) clearance | Dec 31, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shenzhen Dongdixin Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K260412
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


